Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study
- PMID: 18544192
Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study
Abstract
Setting: Five Latin American cities: São Paulo, Brazil; Mexico City, Mexico; Montevideo, Uruguay; Santiago, Chile; Caracas, Venezuela.
Objective: To describe the burden of chronic obstructive pulmonary disease (COPD) in Latin America.
Design: This is a multicentre study. Post-bronchodilator spirometry was used and the main outcome measure was FEV(1)/FVC < 0.7 (fixed ratio criterion). Global Obstructive Lung Disease (GOLD) stages were also analysed.
Results: The combined population aged > or =40 years in the five countries included in the study was approximately 85.3 million. Of these, it was estimated that 12.2 million have airflow obstruction, which corresponds to our prevalence estimate of 14.3%. The proportion of subjects in Stages II-IV of the GOLD classification was 5.6%. Risk factors presenting the highest aetiological fractions for COPD were age, current smoking, indoor exposure to coal and exposure to dust in the workplace. Smoking, the modifiable factor with the strongest aetiological fraction for COPD, affects 29.2% of adults aged > or =40 years in these cities, corresponding to approximately 25 million smokers in this age group.
Conclusion: Prevention of smoking and exposure to pollutants, such as coal and dust, are the interventions most likely to succeed against COPD in Latin America. The information obtained by a collaborative study has been vast and encouraging for other similar studies.
Similar articles
-
Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.Int J Tuberc Lung Dis. 2008 Jul;12(7):703-8. Int J Tuberc Lung Dis. 2008. PMID: 18544191
-
Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.Respir Med. 2008 May;102(5):642-50. doi: 10.1016/j.rmed.2007.12.025. Epub 2008 Mar 7. Respir Med. 2008. PMID: 18314321
-
Impact of bronchodilator use on the prevalence of COPD in population-based samples.COPD. 2007 Jun;4(2):113-20. doi: 10.1080/15412550701341012. COPD. 2007. PMID: 17530504
-
The burden and impact of COPD in Asia and Africa.Int J Tuberc Lung Dis. 2004 Jan;8(1):2-14. Int J Tuberc Lung Dis. 2004. PMID: 14974740 Review.
-
Chronic Obstructive Pulmonary Disease in Latin America.Ann Glob Health. 2019 Jan 22;85(1):7. doi: 10.5334/aogh.2418. Ann Glob Health. 2019. PMID: 30741508 Free PMC article. Review.
Cited by
-
Greater Access to Long Acting Beta2 Agonists Is Associated with Less Hospital Admissions Due to COPD: A Longitudinal Nation-Wide Study.Lung. 2018 Dec;196(6):643-648. doi: 10.1007/s00408-018-0158-y. Epub 2018 Sep 5. Lung. 2018. PMID: 30187130
-
Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world.Int J Chron Obstruct Pulmon Dis. 2012;7:271-82. doi: 10.2147/COPD.S28059. Epub 2012 Apr 5. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 22563246 Free PMC article.
-
The prognostic value of cardiac dysfunction assessed by bedside echocardiography in critically ill patients with COPD requiring mechanical ventilation: a study protocol.BMJ Open. 2014 Sep 25;4(9):e005359. doi: 10.1136/bmjopen-2014-005359. BMJ Open. 2014. PMID: 25256186 Free PMC article.
-
Chronic obstructive pulmonary disease.Indian J Med Res. 2013 Feb;137(2):251-69. Indian J Med Res. 2013. PMID: 23563369 Free PMC article. Review.
-
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2011;6:289-96. doi: 10.2147/COPD.S18181. Epub 2011 May 26. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21697993 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical